骏利亨德森集团 JHG 深 沪
等待开盘 10-30 09:30:00 美东时间
44.49
-0.730
-1.61%
华盛通- 最 高45.57
- 今 开44.93
- 成交量 92.62万股
- 最 低 44.245
- 昨 收 45.22
- 总市值 70.29亿
- 52周最高 49.42
- 市盈率 静 17.37
- 换手率 0.59%
- 52周最低 27.46
- 委 比 -46.34%
- 总股本 1.58亿
- 历史最高 49.42
- 量 比 0.34
- 振 幅 2.93%
- 历史最低 3.37
- 每 手 1
- 风险率 4.07%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Janus Henderson gains as Trian, General Catalyst make takeover offer
Janus Henderson (NYSE:JHG) rose 13% in premarket trading after Trian Fund Management and General Catalyst Group made an offer to buy the remainder of the asset management firm that Trian doesn't alrea...
10-27 20:44
Janus Henderson Confirms Receiving Non-Binding Takeover Proposal From Trian Fund Management For $46/Share
Janus Henderson Group plc (NYSE: JHG) ("Janus Henderson" or the "Company"), announced that it has received a letter outlining a non-binding acquisition proposal (the "Proposal") submitted jointly by Trian Fund
10-27 20:19
关联方认定中 “实质重于形式原则”的适用难点解析
登录新浪财经APP 搜索【信披】查看更多考评等级 关联交易违规是上市公司违规的高发类型，而关联方识别是关联交易规范管理的前提。关于上市公司关...
10-15 07:38
Is the Market Bullish or Bearish on Janus Henderson Group PLC?
Janus Henderson Group PLC's (NYSE:JHG) short interest as a percent of float has...
10-15 04:00
美股大行评级 | 潜在涨幅4347.41%！Ascendiant Capital上调PAVmed目标价至20美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从19美元升至20美元；Ascendiant Capital：维持Plus Therapeutics"买入"评级，目标价从20.5美元升至21美元
10-07 15:04
美股大行评级 | 潜在涨幅1176.6%！Ascendiant Capital上调Society Pass目标价至18美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从15美元升至18美元；Ascendiant Capital：维持Surgepays"买入"评级，目标价从9美元升至9.5美元
10-06 08:35
美股大行评级 | 潜在涨幅216.96%！Kazia Therapeutics获Maxim Group升目标价至20美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持Kazia Therapeutics"买入"评级，目标价从15美元升至20美元；Baird：维持Taysha Gene Therapies"跑赢大市"评级，目标价从7美元升至12美元
10-03 14:32
B of A Securities Maintains Buy on Janus Henderson Group, Raises Price Target to $50
B of A Securities analyst Craig Siegenthaler maintains Janus Henderson Group (NYSE:JHG) with a Buy and raises the price target from $49 to $50.
10-03 02:09
Evercore ISI Group Maintains In-Line on Janus Henderson Group, Raises Price Target to $48
Evercore ISI Group analyst John Dunn maintains Janus Henderson Group (NYSE:JHG) with a In-Line and raises the price target from $45 to $48.
09-05 20:45
Janus Henderson rolls out AI-focused ETF
Janus Henderson Investors, part of Janus Henderson Group (NYSE:JHG), has launched an exchange-traded fund focused on disruptive companies in the artificial intelligence space, it said on Wednesday. Th...
08-20 22:56
